Politics apart, grave shortages are being observed within the public pharmaceutical health care system. Most of these said shortages are essential, and also, costly medicines, that cannot be replaced by out-of-pocket expense.
It is high time that some measure of accountability and transparency is brought to the situation. Both healthcare professionals delivering the service, and the patients on the receiving end, deserve to be kept in the loop.
Unfortunately, a sense of apathy seems to pervade all involved, with no tangible and constructive public debate being held. It is no wonder that most patients I meet tend to shrug their shoulders and say: Does anybody care?